Cooley advised Tocagen on its $97.8 million initial public offering of 9,775,000 shares of common stock. San Diego-based Tocagen, which trades on The NASDAQ Global Select…
Tocagen’s $98 Million Initial Public Offering
Cooley advised Tocagen on its $97.8 million initial public offering of 9,775,000 shares of common stock. San Diego-based Tocagen, which trades on The NASDAQ Global Select…